United Therapeutic (UTHR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Sales | 2,327,500 | 1,936,300 | 1,685,500 | 1,483,300 | 1,448,800 |
| Cost of Goods | 257,500 | 151,600 | 122,500 | 108,100 | 117,600 |
| Gross Profit | 2,070,000 | 1,784,700 | 1,563,000 | 1,375,200 | 1,331,200 |
| Operating Expenses | 885,600 | 805,600 | 1,007,600 | 781,700 | 1,519,400 |
| Operating Income | 1,184,900 | 979,700 | 555,900 | 593,600 | -187,600 |
| Interest Expense | 59,300 | 32,400 | 18,600 | 23,500 | 44,200 |
| Other Income | 148,700 | 3,300 | 56,600 | 68,800 | 66,800 |
| Pre-tax Income | 1,274,300 | 950,600 | 593,900 | 638,900 | -165,000 |
| Income Tax | 289,500 | 223,300 | 118,100 | 124,100 | -60,500 |
| Net Income Continuous | 984,800 | 727,300 | 475,800 | 514,800 | -104,500 |
| Net Income | $984,800 | $727,300 | $475,800 | $514,800 | $-104,500 |
| EPS Basic Total Ops | 21.04 | 15.98 | 10.60 | 11.65 | -2.39 |
| EPS Basic Continuous Ops | 21.04 | 15.98 | 10.60 | 11.65 | -2.39 |
| EPS Diluted Total Ops | 19.81 | 15.00 | 10.06 | 11.54 | -2.39 |
| EPS Diluted Continuous Ops | 19.81 | 15.00 | 10.06 | 11.54 | -2.39 |
| EPS Diluted Before Non-Recurring Items | 19.81 | 15.00 | 10.06 | 11.54 | -2.39 |
| EBITDA(a) | $1,238,100 | $1,031,000 | $605,800 | $643,500 | $-141,700 |